470
Participants
Start Date
July 14, 2023
Primary Completion Date
August 31, 2025
Study Completion Date
November 30, 2025
FreeStyle Libre 3 Continuous Glucose Monitoring System.
Subjects will be randomised to use the FreeStyle Libre 3 system
Self monitoring of blood glucose
Subjects will be randomised to continue with their current glucose monitoring system
Tameside General Hospital, Ashton-under-Lyne
Royal United Hospital, Bath
Queen Elizabeth Hospital, Birmingham
Cambridge University Hospital (Addenbrookes), Cambridge
Darlington Memorial Hospital, Darlington
Ninewells Hospital, Dundee
Princess Alexandra Hospital, Harlow
Northwick Park Hospital, Harrow
Hull Royal Infirmary, Hull
Ipswich Hospital, Ipswich
St James University Hospital, Leeds
Leicester General Hospital, Leicester
King's College Hospital, London
St Mary's Hospital, London
Norfolk and Norwich University Hospital, Norwich
Churchill Hospital, Oxford
Derriford Hospital, Plymouth
The Adam Practice, Poole
Queen Alexandra Hospital, Portsmouth
Northern General Hospital, Sheffield
Moorgreen Hospital, Southampton
Singleton Hospital, Swansea
Wishaw Hospital, Wishaw
Royal Derby Hospital, Derby
Manchester Royal Infirmary, Manchester
Lead Sponsor
Abbott Diabetes Care
INDUSTRY